News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Cornerstone Therapeutics Inc. Gets U.S. FDA Warning
November 23, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
Chiesi, USA
MORE ON THIS TOPIC
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
March 25, 2026
·
1 min read
·
Heather McKenzie
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
March 24, 2026
·
3 min read
·
Heather McKenzie
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
March 23, 2026
·
2 min read
·
Tristan Manalac
FDA
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
March 23, 2026
·
7 min read
·
Heather McKenzie
